Trials / Completed
CompletedNCT01435629
A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin
Open-label, Multicenter, Observational, Non-intervention Study to Retrospectively Evaluate the Efficacy of Norditropin® (Adult Height) in Patients With Achondroplasia/Hypochondroplasia Enrolled in the GH-1941 Study [Follow-up Survey]
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 81 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Japan. The aim of the study is to evaluate the efficacy of somatropin (Norditropin®) on adult height (cm) in patients with achondroplasia / hypochondroplasia enrolled in the GH-1941 study (NCT01516229).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | somatropin | Dosage and administration to be prescribed by the physician as a result of a normal clinical practice. |
Timeline
- Start date
- 2012-11-22
- Primary completion
- 2015-12-04
- Completion
- 2015-12-04
- First posted
- 2011-09-16
- Last updated
- 2017-05-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01435629. Inclusion in this directory is not an endorsement.